Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 28, 2008; 14(32): 5025-5031
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5025
Published online Aug 28, 2008. doi: 10.3748/wjg.14.5025
Table 2 Mice & cell transplantation details
Treatment groups | Mouse group | IP injection | No. of mice |
Negative control (Hepatocyte only) | 1 | 5 x 106 hepatocytes | 3 |
Positive control 1 (HT-29 only) | 2 | 5000 HT-29 cells | 3 |
3 | 100 000 HT-29 cells | 3 | |
4 | 500 000 HT-29 cells | 3 | |
5 | 2 million HT-29 cells | 3 | |
Positive control 2 (Hepatocytes + HT-29) | 6 | 5 million hepatocytes + 5000 HT-29 | 3 |
7 | 5 million hepatocytes + 100 000 HT-29 | 3 | |
8 | 5 million hepatocytes + 500 000 HT-29 | 3 | |
9 | 5 million hepatocytes + 2 million HT-29 | 3 | |
Bead (Hepatocyte + HT-29) | 10 | 5 million hepatocytes + 5000 HT-29 | 3 |
11 | 5 million hepatocytes + 100 000 HT-29 | 3 | |
12 | 5 million hepatocytes + 500 000 HT-29 | 3 | |
13 | 5 million hepatocytes + 2 million HT-29 | 3 |
- Citation: Gunasegaram A, Akhter J, Yao P, Johnson LA, Riodan SM, Morris DL. Hepatocytes isolated from neoplastic liver-immunomagnetic purging as a new source for transplantation. World J Gastroenterol 2008; 14(32): 5025-5031
- URL: https://www.wjgnet.com/1007-9327/full/v14/i32/5025.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5025